About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
BNF Category
1: Gastro-intestinal system
2: Cardiovascular system
3: Respiratory system
4: Central nervous system
5: Infections
6: Endocrine system
7: Obstetrics, gynaecology, and urinary-tract disorders
8: Malignant disease and immunosuppression
9: Nutrition and blood
10: Musculoskeletal and joint diseases
11: Eye
12: Ear, nose, and oropharynx
13: Skin
14: Immunological products and vaccines
15: Anaesthesia
Appendix 7
Appendix 8 Wound management products and elasticated garments
Non-BNF miscellaneous
Emergency treatment of poisoning
6.1 Drugs used in diabetes
6.2 Thyroid and antithyroid drugs
6.3 Corticosteroids
6.4 Sex hormones
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.6 Drugs affecting bone metabolism
6.7 Other endocrine drugs
6.6.1 Calcitonin and parathyroid hormone (contains Preotact entry)
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
447 library items
in 6.6 Drugs affecting bone metabolism
Filter results by:
Date Published
2012 (24)
2011 (84)
2010 (88)
2009 (59)
2008 (68)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
6: Endocrine system (
remove
)
,
6.6 Drugs affecting bone metabolism (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 447
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
CADTH Bulletin: Odanacatib for postmenopausal osteoporosis
Source:
Canadian Agency for Drugs and Technologies in Health (CADTH)
,
Date published:
15/05/2012
Category:
6.6 Drugs affecting bone metabolism
|
New drugs
|
Osteoporosis
NeLM
Area:
News
Link
2.
Psychometric properties of the Oteoporosis-Specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates
Source:
Annals of Pharmacotherapy
,
Date published:
15/05/2012
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Bone Diseases
|
Compliance
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
3.
Perspective on safety and optimal duration of use of bisphosphonates
Source:
New England Journal of Medicine (NEJM)
,
Date published:
10/05/2012
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Adverse Drug Reactions
|
Osteoporosis
NeLM
Area:
News
Link to FDA article
Link to article on duration
4.
Persistence and compliance of medications used in the treatment of osteoporosis - analysis using a large scale, representative, longitudinal German database
Source:
International Journal of Clinical Pharmacology and Therapeutics
,
Date published:
01/05/2012
Category:
6.6.1 Calcitonin and parathyroid hormone (contains Preotact entry)
|
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Compliance
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
5.
Horizon scanning: US FDA rejects denosumab (Xgeva) for preventing prostate cancer spread to bone
Source:
Reuters Health News
,
Date published:
30/04/2012
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Cancer: prostate
|
Food &Drug Administration (FDA)
|
Licence extension
NeLM
Area:
News
Link – registration required
6.
Inflammatory ocular adverse events with use of oral bisphosphonates: retrospective cohort study
Source:
CMAJ
,
Date published:
05/04/2012
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Adverse Drug Reactions
|
Ophthalmology
NeLM
Area:
News
Abstract
7.
Letters sent to healthcare professionals by MHRA on safety of medicines (March 2012)
Source:
MHRA
,
Date published:
05/04/2012
Category:
5.2.1 Triazole antifungals
|
6.1.2 Antidiabetic drugs
|
6.6 Drugs affecting bone metabolism
|
10.1.3 Drugs that suppress the rheumatic disease process
|
Medical staff
|
Medicines and Healthcare products Regulatory Agency (MHRA)
NeLM
Area:
News
Link
8.
NICE issues Appraisal Consultation Document on denosumab for bone metastases from solid tumours
Source:
NICE
,
Date published:
30/03/2012
Category:
6.6.2 Bisphosphonates and other drugs affecting bone metabolism
|
Cancer: breast
|
Cancer: prostate
|
Clinical guidelines
|
National Institute of Clinical Excellence (NICE)
|
Rheumatology
NeLM
Area:
News
Link
9.
Impact of a pharmacist-directed intervention in postmenopausal women after fracture
Source:
American Journal of Health-System Pharmacy
,
Date published:
30/03/2012
Category:
6.6 Drugs affecting bone metabolism
|
Compliance
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
10.
6.6 Drugs affecting bone metabolism
Source:
Chelsea and Westminster Hospital Formulary
,
Date published:
26/03/2012
Category:
6.6 Drugs affecting bone metabolism
NeLM
Area:
Formularies
>
Trusts
>
Chelsea & Westminster Hospital Formulary
>
Products
>
Approved Prescribing List
>
6: Endocrine system
Results 1 - 10 of 447
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next